Showing results (1-10 of 306) with videos related to
Sort By:
Pageof 31
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 4, 2019
The Internal Validity of Discrete Choice Experiment Data: A Testing Tool for Quantitative AssessmentsF Reed Johnson, Jui-Chen Yang, Shelby D ReedValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 1, 2021
Quantifying Value of HopeShelby D Reed, Jui-Chen Yang, Juan Marcos Gonzalez, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 19, 2021
Is Easier Better Than Harder? An Experiment on Choice Experiments for Benefit-Risk Tradeoff PreferencesJui-Chen Yang, Shelby D Reed, Steve Hass, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 13, 2019
Something Is Better Than Nothing: The Value of Active Intervention in Stated Preferences for Treatments to Delay Onset of Alzheimer's Disease SymptomsF Reed Johnson, Rachael L DiSantostefano, Jui-Chen Yang, et al.Epilepsy & Behavior : E&B|January 11, 2022
Patient preferences pertaining to treatment options for drug-resistant focal epilepsySaurabh R Sinha, Jui-Chen Yang, Matthew J Wallace, et al.Gynecologic Oncology|May 31, 2021
The preferences of women with ovarian cancer for oral versus intravenous recurrence regimensLaura J Havrilesky, Amelia L Scott, Brittany A Davidson, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 5, 2026
What is the Consensus Value of Patients' Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel DiseaseF Reed Johnson, Juan Marcos Gonzalez, Jui-Chen YangGynecologic Oncology|January 27, 2020
Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatmentLaura J Havrilesky, Stephanie Lim, Jessie A Ehrisman, et al.Pharmacoeconomics|May 3, 2023
How Much Better is Faster? Value Adjustments for Health-Improvement SequencesF Reed Johnson, Juan Marcos Gonzalez, John J Sheehan, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2019
Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic EvaluationsF Reed Johnson, Frank I Scott, Shelby D Reed, et al.Pageof 31